课题基金 / 基金详情

5G-LEAP - Flexible Open RAN Platform for 5G and beyond networks

5G-LEAP - Flexible Open RAN Platform for 5G and beyond networks
5G-LEAP - 适用于 5G 及其他网络的灵活开放 RAN 平台
批准号:
576390-2022
负责人:
Boutaba, RaoufR
金额:
$6.92万
依托单位:
依托单位国家:
加拿大
项目类别:
Alliance Grants
财政年份:
2022
资助国家:
加拿大
项目状态:
已结题
起止时间:
2022-01-01 至 2023-12-31
关键词:

项目摘要

项目成果

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
5G and beyond mobile networks are expected to support a variety of emerging use-cases, such as holographic telepresence, immersive extended-reality, cloud gaming, and autonomous driving. Such a diverse set of services imposes strict requirements on the mobile network along several dimensions, such as throughput, latency, and reliability. Network slicing has been envisaged as a key enabler to satisfy these diverse requirements, by creating multiple isolated end-to-end virtual networks dedicated to different services, on top of a common physical infrastructure. However, the implementation of network slicing is not without its challenges. This project addresses some of these fundamental challenges that are impeding the realization of end-to-end slicing in mobile networks most notably in the Radio Access Network (RAN). The flexible and reconfigurable nature of end-to-end network slices, building on Open RAN technologies, will allow for the realization of new use cases with stringent performance requirements that cannot be guaranteed by legacy mobile networks. This research will benefit Rogers by facilitating the integration of hardware and software from diverse vendors and by enabling new services and business verticals.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
国内基金
海外基金
大弹涂鱼CD40作为MOSPD2共受体调控LEAP2趋化单核巨噬细胞的分子机制
  • 批准号:
    LZ23C190001
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2023
  • 负责人:
    陈炯
  • 依托单位:
mTORC1-CDX4-LEAP2调控轴调节鸡采食量的作用及机制研究
  • 批准号:
    32302725
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    30.00万元
  • 批准年份:
    2023
  • 负责人:
    陈建飞
  • 依托单位:
大弹涂鱼MOSPD2在介导LEAP2调控单核巨噬细胞功能中的内吞入胞和胞内“脚手架”作用机制
  • 批准号:
    --
  • 项目类别:
    面上项目
  • 资助金额:
    58万元
  • 批准年份:
    2021
  • 负责人:
    陈炯
  • 依托单位:
代谢疾病的新型潜在治疗靶点:Ghrelin / GHSR1A / LEAP2在2型糖尿病中的作用以及对NAFLD的影响
  • 批准号:
    --
  • 项目类别:
    --
  • 资助金额:
    10万元
  • 批准年份:
    2020
  • 负责人:
    李希
  • 依托单位: